Vizient Announces Expansion of Novaplus Enhanced Supply in Med/Surg, Pharmacy
The new med/surg categories are durable medical equipment, sterile inhalation water and non-invasive ventilation. The antidotes category has 60 unique drugs, with 14 products already added to the program.
MoreVizient and RISCS Announce Pilot Program to Improve Pharmaceutical Supply Chain Resilience
Vizient Inc. and RISCS, Inc. today announced a joint pilot program aimed at enhancing assurance of pharmaceutical supply. Once implemented, the program would use a rating system to enable the evaluation of critical aspects of a resilient supply chain and provide increased transparency.
MoreVizient Shares Feedback for FDA User Fee Acts Reauthorization
Vizient provided comments and feedback to Congress on the Food and Drug Administration’s (FDA) draft agreements for the next iteration of the Medical Device User Fee Act (MDUFA) and the Prescription Drug User Fee Act (PDUFA). MDUFA and PDUFA authorize FDA to collect user fees to support FDA’s review of medical devices and prescription drug applications, respectively, and improve the efficiency of FDA’s regulatory processes.
MoreVizient Improves Visibility into Domestically Manufactured Supplies
Great Place to Work® Names Vizient One of the Fortune 100 Best Companies to Work For® in 2022, Ranking #56
Vizient Announces 97 New, Renewed or Expanded Member Agreements in 2021
The agreements reflect the value of Vizient’s solutions and services for health care providers.
MoreVizient Medical Device Tech Watch Provides Trends in Transcatheter Valve Replacement and a Model for Assessing New Technology in Musculoskeletal Care
Vizient Announces Strategic Partnership With Phrase Health to Enable Real-Time Insights Into Provider Ordering Practices
Vizient announced an agreement with Phrase Health to offer quality improvement workflow and process solutions for improving patient outcomes.
More